[{"address1": "1111 Kane Concourse", "address2": "Suite 301", "city": "Bay Harbor Islands", "state": "FL", "zip": "33154", "country": "United States", "phone": "781 652 4500", "website": "https://www.avenuetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alexandra  MacLean M.D.", "age": 55, "title": "CEO & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 413200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Jin", "age": 32, "title": "Interim CFO, COO & Corporate Secretary", "yearBorn": 1991, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lindsay Allan Rosenwald", "age": 68, "title": "Executive Director", "yearBorn": 1955, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Xiaoqin  Lu M.D.", "age": 48, "title": "Consultant", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 1046836, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott A. Reines M.D., Ph.D.", "age": 76, "title": "Interim Chief Medical Officer", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 69120, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Srinivas  Subramanian", "age": 52, "title": "Executive Vice President", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.134, "open": 0.1001, "dayLow": 0.089, "dayHigh": 0.104, "regularMarketPreviousClose": 0.134, "regularMarketOpen": 0.1001, "regularMarketDayLow": 0.089, "regularMarketDayHigh": 0.104, "beta": -0.26, "forwardPE": -0.24702701, "volume": 9998417, "regularMarketVolume": 9998417, "averageVolume": 1505491, "averageVolume10days": 785800, "averageDailyVolume10Day": 785800, "bid": 0.09, "bidSize": 800, "marketCap": 4045427, "fiftyTwoWeekLow": 0.089, "fiftyTwoWeekHigh": 1.25, "fiftyDayAverage": 0.15078, "twoHundredDayAverage": 0.432425, "currency": "USD", "enterpriseValue": 3219929, "floatShares": 39025073, "sharesOutstanding": 44260700, "sharesShort": 283132, "sharesShortPriorMonth": 163461, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0064, "heldPercentInsiders": 0.11813, "heldPercentInstitutions": 0.02795, "shortRatio": 0.15, "shortPercentOfFloat": 0.0064999997, "impliedSharesOutstanding": 44260700, "bookValue": 0.062, "priceToBook": 1.4741936, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "earningsQuarterlyGrowth": 0.113, "netIncomeToCommon": -10377000, "trailingEps": -0.98, "forwardEps": -0.37, "lastSplitFactor": "1:15", "lastSplitDate": 1663891200, "52WeekChange": -0.85274726, "SandP52WeekChange": 0.25013864, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ATXI", "underlyingSymbol": "ATXI", "shortName": "Avenue Therapeutics, Inc.", "longName": "Avenue Therapeutics, Inc.", "firstTradeDateEpochUtc": 1498570200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ab3c15b5-e280-3b5c-b842-8e87c6276492", "messageBoardId": "finmb_310815442", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.0914, "targetHighPrice": 0.75, "targetLowPrice": 0.75, "targetMeanPrice": 0.75, "targetMedianPrice": 0.75, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 1783000, "totalCashPerShare": 0.04, "quickRatio": 1.491, "currentRatio": 1.547, "returnOnAssets": -2.09028, "returnOnEquity": -5.35102, "freeCashflow": -13494500, "operatingCashflow": -9451000, "earningsGrowth": -0.763, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-24"}]